Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Qiao, Boling ^a,c,d   Scott, Gina B ^a   Elliott, Faye ^a   Vaslin, Laurence ^b   Bentley, Johanne ^a   Hall, Janet ^b   Bishop, D T ^a   Knowles, Margaret A ^a   Kiltie, Anne E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b INSERM U612   (France)

^c INSTITUT CURIE   (France)

^d United Kingdom and Gray Institute for Radiation Oncology and Biology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; DNA BINDING PROTEIN; XPC PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RNA STABILITY; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; BLADDER TUMOR; CELL LINE; GENETICS; METABOLISM; PROTEIN SYNTHESIS; RISK FACTOR;

3' UNTRANSLATED REGIONS; ALLELES; CELL LINE; DNA-BINDING PROTEINS; HOMOZYGOTE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BIOSYNTHESIS; RISK FACTORS; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 79959216989     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-84     Document Type: Article

References (13)

1. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001, 1:22-33. 10.1038/35094000, 11900249.
2. Sugasawa K, Ng JM, Masutani C, Iwai S, van der Spek PJ, Eker AP, Hanaoka F, Bootsma D, Hoeijmakers JH. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol Cell 1998, 2:223-232. 10.1016/S1097-2765(00)80132-X, 9734359.
3. D'Errico M, Parlanti E, Teson M, de Jesus BM, Degan P, Calcagnile A, Jaruga P, Bjoras M, Crescenzi M, Pedrini AM, Egly JM, Zambruno G, Stefanini M, Dizdaroglu M, Dogliotti E. New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J 2006, 25:4305-4315. 10.1038/sj.emboj.7601277, 1570445, 16957781.
4. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006, 15:2537-2541. 10.1158/1055-9965.EPI-06-0288, 17164382.
5. Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, Yuan JM, Matullo G, Fletcher T, Benhamou S, Taylor JA, Placidi D, Zhang ZF, Steineck G, Rothman N, Kogevinas M, Silverman D, Malats N, Chanock S, Wu X, Karagas MR, Andrew AS, Nelson HH, Bishop DT, Sak SC, Choudhury A, Barrett JH, Elliot F, Corral R, Joshi AD, Gago-Dominguez M, Cortessis VK, Xiang YB, Gao YT, Vineis P, Sacerdote C, Guarrera S, Polidoro S, Allione A, Gurzau E, Koppova K, Kumar R, Rudnai P, Porru S, Carta A, Campagna M, Arici C, Park SS, Garcia-Closas M. International Consortium of Bladder Cancer: Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Res 2009, 69:6857-6864. 10.1158/0008-5472.CAN-09-1091, 2782435, 19706757.
6. Qiao B, Ansari AH, Scott GB, Sak SC, Chambers PA, Elliott F, Teo MT, Bentley J, Churchman M, Hall J, Taylor CF, Bishop TD, Knowles MA, Kiltie AE. In vitro functional effects of XPC gene rare variants from bladder cancer patients. Carcinogenesis 2001, 32:516-21.
7. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 2003, 12:1168-1174.
8. Li L, Bales ES, Peterson CA, Legerski RJ. Characterization of molecular defects in xeroderma pigmentosum group C. Nat Genet 1993, 5:413-417. 10.1038/ng1293-413, 8298653.
9. Ioannidis JP, Thomas G, Daly MJ. Validating, augmenting and refining genome-wide association signals. Nat Rev Genet 2009, 10:318-329.
10. Emmert S, Kobayashi N, Khan SG, Kraemer KH. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts. Proc Natl Acad Sci USA 2000, 97:2151-2156. 10.1073/pnas.040559697, 15769, 10681431.
11. Boffa MB, Maret D, Hamill JD, Bastajian N, Crainich P, Jenny NS, Tang Z, Macy EM, Tracy RP, Franco RF, Nesheim ME, Koschinsky ML. Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis. Blood 2008, 111:183-189. 10.1182/blood-2007-03-078543, 17855631.
12. Kamiyama M, Kobayashi M, Araki S, Iida A, Tsunoda T, Kawai K, Imanishi M, Nomura M, Babazono T, Iwamoto Y, Kashiwagi A, Kaku K, Kawamori R, Ng DP, Hansen T, Gaede P, Pedersen O, Nakamura Y, Maeda S. Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Hum Genet 2007, 122:397-407. 10.1007/s00439-007-0414-3, 17671797.
13. Wang J, Pitarque M, Ingelman-Sundberg M. 3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. Biochem Biophys Res Commun 2006, 340:491-497. 10.1016/j.bbrc.2005.12.035, 16378601.